Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+T Cells

Journal: Cancer Research

Published: 2018-06-01

DOI: 10.1158/0008-5472.can-17-2153

Affiliations: 8

Authors: 13

Go to article
Institutions FC
Department of Surgery, MUSC, United States of America (USA) 0.42
Department of Microbiology and Immunology, MUSC, United States of America (USA) 0.15
Altor BioScience Corporation, United States of America (USA) 0.15
Department of Public Health Sciences (DPHS), MUSC, United States of America (USA) 0.08
Department of Dermatology and Dermatologic Surgery, MUSC, United States of America (USA) 0.08
Faculty of Medicine, Tanta University, Egypt 0.04
Faculty of Science, Tanta University, Egypt 0.04
Department of Medicine, MUSC, United States of America (USA) 0.04

Return